INS and hematocrit: Angiotensin II (AT-II) can cause either IR in hypertensive individuals or incident HT among those who are already insulin-resistant, hence angiotensin receptor blockers are a better choice compared to calcium channel blockers for blood pressure control among non-diabetic patients with HT.